procainamide has been researched along with CHARGE Association in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "CHARGE syndrome is an autosomal dominant congenital disorder caused primarily by mutations in the CHD7 gene." | 1.56 | Chemical screens in a zebrafish model of CHARGE syndrome identifies small molecules that ameliorate disease-like phenotypes in embryo. ( Asad, Z; Sachidanandan, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asad, Z | 1 |
| Sachidanandan, C | 1 |
1 other study available for procainamide and CHARGE Association
| Article | Year |
|---|---|
Chemical screens in a zebrafish model of CHARGE syndrome identifies small molecules that ameliorate disease-like phenotypes in embryo.
Topics: Animals; Animals, Genetically Modified; Cartilage; CHARGE Syndrome; Dipeptides; Disease Models, Anim | 2020 |